<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8809320</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1600</journal-id>
<journal-id journal-id-type="nlm-ta">Neuron</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuron</journal-id>
<journal-title-group>
<journal-title>Neuron</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-6273</issn>
<issn pub-type="epub">1097-4199</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26590342</article-id>
<article-id pub-id-type="pmc">4656196</article-id>
<article-id pub-id-type="doi">10.1016/j.neuron.2015.10.029</article-id>
<article-id pub-id-type="manuscript">NIHMS736385</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ito-Ishida</surname>
<given-names>Aya</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ure</surname>
<given-names>Kerstin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Hongmei</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Swann</surname>
<given-names>John W.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>Huda Y.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA</aff>
<aff id="A2"><label>2</label>Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA</aff>
<aff id="A4"><label>4</label>Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030, USA</aff>
<aff id="A5"><label>5</label>Jan and Dan Duncan Neurological Research Institute at Texas Childrenâ€™s Hospital, Houston, TX 77030, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence: <email>hzoghbi@bcm.edu</email></corresp>
<fn id="FN2">
<label>6</label>
<p>Co-first author</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>18</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>88</volume>
<issue>4</issue>
<fpage>651</fpage>
<lpage>658</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuron.2015.10.029-->
<abstract>
<title>SUMMARY</title>
<p id="P2">Inhibitory neurons are critical for proper brain function, and their dysfunction is implicated in several disorders, including autism, schizophrenia, and Rett syndrome. These neurons are heterogeneous, and it is unclear which subtypes contribute to specific neurological phenotypes. We deleted <italic>Mecp2</italic>, the mouse homolog of the gene that causes Rett syndrome, from the two most populous subtypes, parvalbumin-positive (PV+) and somatostatin-positive (SOM+) neurons. Loss of MeCP2 partially impairs the affected neuron, allowing us to assess the function of each subtype without profound disruption of neuronal circuitry. We found that mice lacking MeCP2 in either PV+ or SOM+ neurons have distinct, non-overlapping neurological features: mice lacking MeCP2 in PV+ neurons developed motor, sensory, memory, and social deficits, whereas those lacking MeCP2 in SOM+ neurons exhibited seizures and stereotypies. Our findings indicate that PV+ and SOM+ neurons contribute complementary aspects of the Rett phenotype and may have modular roles in regulating specific behaviors.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>